Don’t let the high cost of brand SGLT2/metformin combination therapy disrupt your diabetes treatment. We help eligible patients access Xigduo XR (dapagliflozin/metformin extended-release) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Xigduo XR PAP for T2DM patients.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$680 | Save ~$610/mo |
| CVS Pharmacy | ~$700 | Save ~$630/mo |
| Walmart | ~$540 | Save ~$470/mo |
| Costco | ~$520 | Save ~$450/mo |
Components | ~$600 | Similar |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
PAP at no cost.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Xigduo XR:
Still $500–$700 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Xigduo XR assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Xigduo XR is fixed-dose Farxiga (dapagliflozin SGLT2) + metformin ER. SGLT2 inhibitors have transformed T2DM care with CV/renal outcome benefits proven in trials (DAPA-HF, DAPA-CKD, EMPA-REG).
How Xigduo XR Works:
Dapagliflozin inhibits SGLT2 in kidneys — causes urinary glucose excretion, modest weight loss, BP reduction, CV/renal protection. Metformin reduces hepatic glucose production.
Beyond glycemic control: Farxiga reduces HF hospitalizations (including in non-diabetics with HFrEF and HFpEF), slows CKD progression. Recommended in T2DM with CVD, HF, or CKD.
Form and use:
Xigduo XR once daily with morning meal.
Generic availability:
No generic Xigduo XR. Generic metformin ER widely available. Farxiga brand only (until generic ~2026–2027). Other SGLT2: Jardiance, Steglatro, Invokana (all brand).
Warnings:
BOXED metformin lactic acidosis. SGLT2: genital mycotic infections, UTI, DKA (including euglycemic), volume depletion, Fournier gangrene, lower limb amputation risk (signal more with canagliflozin), bone fracture risk.
$500–$700/month. Generic metformin + brand Farxiga similar.
Proven CV/renal benefits beyond glycemic control. Recommended in T2DM with CVD/HF/CKD.
Farxiga and Jardiance are similar SGLT2 inhibitors. Both effective; Xigduo is Farxiga + metformin combo.
Genital yeast infections common, UTIs, DKA risk (rare but serious). Drink fluids, hold for illness.
Components separately. Other SGLT2 may have different coverage.
If struggling with Xigduo XR cost, we can help. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.